Telix Pharmaceuticals (ASX:TLX) Down 55% Amid Lawsuit: Is It Time to Buy or Sell?
Telix Pharmaceuticals (ASX: TLX) has been crushed in 2025. The stock has fallen roughly 55% from its February high of…
Star Entertainment (ASX:SGR) Loses Another CEO: Is This Casino Stock Worth the Gamble?
Star Entertainment CEO Steps Down: What Next for SGR? Star Entertainment (ASX: SGR) shares rose 9.52% to close at A$0.12…
Karoon Energy (ASX:KAR) Drops to 6x P/E: Time to Buy the Dip?
Karoon Energy trades on 6x earnings as oil sentiment turns sour Karoon Energy (ASX: KAR) fell alongside the broader ASX…
Recce Pharmaceuticals (ASX: RCE) Secures A$85M R&D Backing: Is It a Buy Before Phase 3 Results?
Recce secures A$85m R&D backing as Phase 3 nears Recce Pharmaceuticals (ASX: RCE) hit a one-week high after landing an…
Will Weebit Nano (ASX:WBT) Deliver on Its Foundry Ambitions Before 2026?
Weebit Nano’s Year-End Challenge Weebit Nano (ASX: WBT) has now crossed an important threshold by moving into commercial revenue, but…
After a 20% Slide, Is Life360 (ASX:360) Now a Hidden Growth Opportunity?
Life360’s 20% Drop Raises the Question, Time to Buy or Stay Away? Life360 (ASX: 360) has been one of the…
DroneShield Bags $50M Deal as Repeat Buyers Fuel Its Flight Path
DroneShield’s $50M Contract Sends a Clear Signal DroneShield (ASX: DRO) announced this morning that it has secured a very large…
Drilling results from ASX explorers can send them surging or plunging! So here are 4 key things investors need to look for
Drilling results from ASX explorers are seen on the Market Announcements platform each day. Why do some results cause some…
Challenger (ASX:CGF): Apollo’s sell out was their loss but other investors’ gain!
When we last wrote about Challenger (ASX:CGF), in September 2024, investors were panicking because Apollo (a global fund manager that…
Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?
Cynata Therapeutics (ASX: CYP) has completed patient enrollment in its Phase 2 clinical trial of a stem cell treatment called…
Medallion Metals’ $60M War Chest Sets Up 2026 Production Push- Is the Stock a Buy?
Medallion’s A$60M Raise Sets Up a 2026 Production Push Medallion Metals (ASX: MM8) has secured an A$60 million funding package,…
Neuren Pharmaceuticals (ASX:NEU) Gets FDA Approval- Is It a Buy?
Neuren Pharmaceuticals (ASX: NEU) rose 2.5% yesterday after the US FDA approved DAYBUE STIX, a new powder formulation of its…
Gorilla Gold (ASX: GG8) Adds 900% More Gold- Time to Buy or Cash Out?
Gorilla Gold surges after a 900% resource increase: what’s next? Gorilla Gold (ASX: GG8) climbed another 5% yesterday after announcing…
FortifAI (ASX:FAI) Acquires NOL8 in a Bold Play to Power the Data Future
FortifAI’s NOL8 Acquisition Signals Next-Level Ambitions in Data Processing FortifAI Limited (ASX:FAI) surged 25% today after announcing a strategic pivot…
Fortescue (ASX:FMG) Digs Deeper Into Copper with Alta Acquisition
Fortescue’s C$139M Alta Deal Explained Fortescue (ASX:FMG) is moving to acquire the remaining 64 percent of Alta Copper Corp, a…